Risk factor
Very poor trading liquidity
Profitability factor
Very poor margins and returns
About
Operating both domestically in India and across global markets, Alkali Metals Limited specializes in the production and distribution of a diverse range of chemical goods. Their comprehensive product catalog includes Active Pharmaceutical Ingredients (APIs), a vast selection of pyridine compounds such as acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic pyridine compounds, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, and pyridine n-oxide. The company also offers related nitrogen-containing heterocycles like pyrimidine, tetrazole, and triazole compounds, in addition to azaindole, various metal derivatives (including potassium and sodium compounds), boronic acids, specialty fine chemicals, and advanced materials for DSSC and OLED applications. These chemical products serve critical roles across numerous industries, including as pharmaceutical intermediates for anti-retrovirals, flu vaccines, antibiotics, and cardiovascular/anti-inflammatory treatments, as well as in agrochemicals and the automotive sector. Established in 1968, Alkali Metals Limited maintains its headquarters in Hyderabad, India.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, ov